Biopsy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Biopsy Devices Market Growth and it is segmented by Product (Needle-based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Needles, Vacuum-assisted Biopsy Devices), Procedure Trays, Localization Wires, and Other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). it covers the estimated market sizes and trends for 17 different countries across major regions, globally. The Market offers the value (in USD million) for the above segments.

Biopsy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Biopsy Devices Market Size

Biopsy Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 2.24 Billion
Market Size (2030) USD 2.72 Billion
CAGR (2025 - 2030) 4.02 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Biopsy Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Biopsy Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Biopsy Devices Market Analysis

The Global Biopsy Devices Market size is estimated at USD 2.24 billion in 2025, and is expected to reach USD 2.72 billion by 2030, at a CAGR of 4.02% during the forecast period (2025-2030).

During the COVID 19 pandemic, the biopsy devices market was significantly impacted due to the decrease in the number of biopsy procedures due to covid restrictions. For instance, according to the study published on 'Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritization)' in 'International Journal of Surgery' in May 2020, all specialties had written recommendations for how to cope during this crisis, which has had a substantial impact on surgical practice. All disciplines have had to prioritize the importance of their daily surgical procedures and, where practicable, pursue non-surgical therapy options. The rise in non-surgical procedures and avoiding surgical practices have negatively impacted the market growth during the pandemic.

The propelling factors for the growth of the biopsy devices market include the increasing preference for minimally invasive procedures, an increase in the number of cancer cases worldwide, and initiatives undertaken by the governments for diagnosis. Biopsy has been one of the major diagnosis techniques for cancer disorders and is widely used in the diagnosis of breast, skin, and prostate cancer. According to the World Cancer Report, cancer rates could further increase by 50% to 15 million new cases by 2020. Therefore, with the increasing incidence of cancer cases and developments in the biopsy devices, the market is expected to increase in the forecast period.

There is also a demand for minimally invasive biopsy procedures that is rising at a significant rate in the market. The different types of technologies and products, such as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness the high growth during the forecast period. In addition, the growing awareness regarding breast cancer treatment and diagnosis will support the increase in the biopsy devices market size in the upcoming years. There are many countries that hold programs for the early diagnosis of breast cancer. For instance, according to the study published on 'Increasing breast cancer awareness and breast examination practices among women through health education and capacity building of primary healthcare providers: a pre-post intervention study in low socioeconomic area of Mumbai, India' in "BMJ Journal' in April 2021, following the health education interventions among these subpopulations in India, there was a significant improvement in knowledge of breast cancer signs and symptoms, risk factors, and breast self-examination behaviors among study participants.

Therefore, such initiatives are expected to accelerate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business in the foreseeable future.

Biopsy Devices Industry Overview

The biopsy devices market is fragmented due to a large number of market players in this market and the increasing product launches by them. The major market players operating in the biopsy devices market are Hologic, C.R. Bard Inc., and Danaher Corporation. These companies are undertaking strategies, such as product launches through technological innovations and partnerships to gain profits in the industry. Thus, new product launches are the most preferred strategy, followed by collaborations and geographical expansion for market capitalization.

Biopsy Devices Market Leaders

  1. Argon Medical Devices

  2. Cook Medical

  3. Hologic Inc.

  4. Boston Scientific

  5. Becton, Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
Biopsy Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Biopsy Devices Market News

  • In March 2021, The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy was launched by IZI Medical Products LLC ("IZI"), a prominent developer of medical devices used in interventional radiology and interventional oncology treatments. The Quick-Core Auto is a lightweight, completely automatic biopsy equipment that adds on the reliability, precision, and quality of IZI's Quick-Core semi-automatic biopsy system.
  • In November 2020, NeoDynamics AB, a MedTech business dedicated to improving breast cancer diagnosis and treatment, entered a partnership with the Buckinghamshire Healthcare NHS Trust in London for its NeoNavia pulse biopsy technology.

Biopsy Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions & Market Definitions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally Invasive Procedures
    • 4.2.2 Increase in the Number of Cancer Cases Worldwide
    • 4.2.3 Initiatives Undertaken by Governments for Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls
    • 4.3.2 Availability of Alternative Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Needle-based Biopsy Instruments
    • 5.1.1.1 Core Biopsy Devices
    • 5.1.1.2 Aspiration Biopsy Needles
    • 5.1.1.3 Vacuum-assisted Biopsy Devices
    • 5.1.2 Procedure Trays
    • 5.1.3 Localization Wires
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Breast Biopsy
    • 5.2.2 Lung Biopsy
    • 5.2.3 Colorectal Biopsy
    • 5.2.4 Prostate Biopsy
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Hologic Inc.
    • 6.1.3 Danaher Corporation
    • 6.1.4 Cook Medical
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Intact Medical Corporation
    • 6.1.7 Gallini Medical
    • 6.1.8 TSK Laboratory Europe BV
    • 6.1.9 Argon Medical Devices
    • 6.1.10 B. Braun Melsungen AG
    • 6.1.11 Cardinal Health Inc.
    • 6.1.12 Medtronic PLC
    • 6.1.13 Fujifilm Holdings Corportation
    • 6.1.14 INRAD Inc.
    • 6.1.15 Olympus Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Biopsy Devices Industry Segmentation

As per the scope of the report, a biopsy is a process that helps in the removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists to confirm the presence of cancerous tissues. Therefore, biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. The biopsy devices market has been segmented by product (needle-based biopsy instruments, procedure trays, localization wires, and other products), application (breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Needle-based Biopsy Instruments Core Biopsy Devices
Aspiration Biopsy Needles
Vacuum-assisted Biopsy Devices
Procedure Trays
Localization Wires
Other Products
By Application Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Biopsy Devices Market Research FAQs

How big is the Global Biopsy Devices Market?

The Global Biopsy Devices Market size is expected to reach USD 2.24 billion in 2025 and grow at a CAGR of 4.02% to reach USD 2.72 billion by 2030.

What is the current Global Biopsy Devices Market size?

In 2025, the Global Biopsy Devices Market size is expected to reach USD 2.24 billion.

Who are the key players in Global Biopsy Devices Market?

Argon Medical Devices, Cook Medical, Hologic Inc., Boston Scientific and Becton, Dickinson and Company are the major companies operating in the Global Biopsy Devices Market.

Which is the fastest growing region in Global Biopsy Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Biopsy Devices Market?

In 2025, the North America accounts for the largest market share in Global Biopsy Devices Market.

What years does this Global Biopsy Devices Market cover, and what was the market size in 2024?

In 2024, the Global Biopsy Devices Market size was estimated at USD 2.15 billion. The report covers the Global Biopsy Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Biopsy Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Biopsy Devices Industry Report

Statistics for the 2025 Global Biopsy Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Biopsy Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.